Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GJB2 | P29033 | 3/20 | 0.57 |
| ▸ | NT5E | P21589 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 8/20 | 0.51 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.51 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.51 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.49 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.49 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.49 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.49 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.49 |
| ▸ | GJA1 | P17302 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | CDC25B | P30305 | 6/20 | 0.48 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4909410 | 1.00 | GJB2 (0.57) | GJB2NT5ESLC6A2PTPN1PTPN2 | |
| SCHEMBL8221413 | 0.93 | NT5E (0.54) | GJB2NT5ESLC6A2PTPN1PTPN2 | |
| SCHEMBL10523689 | 0.93 | NT5E (0.54) | GJB2NT5ESLC6A2PTPN1PTPN2 | |
| SCHEMBL977852 | 0.93 | NT5E (0.54) | GJB2NT5ESLC6A2PTPN1PTPN2 | |
| SCHEMBL18744555 | 0.93 | NT5E (0.54) | GJB2NT5ESLC6A2PTPN1PTPN2 | |
| SCHEMBL10523693 | 0.93 | NT5E (0.54) | GJB2NT5ESLC6A2PTPN1PTPN2 | |
| SCHEMBL11311474 | 0.92 | SLC6A2 (0.53) | GJB2NT5ESLC6A2PTPN1PTPN2 | |
| SCHEMBL5314955 | 0.91 | GJB2 (0.55) | GJB2NT5ESLC6A2PTPN1PTPN2 | |
| SCHEMBL23705129 | 0.90 | SSTR1 (0.58) | GJB2NT5EPTPN1PTPN2PTPN11 | |
| SCHEMBL17665036 | 0.90 | SSTR1 (0.58) | GJB2NT5EPTPN1PTPN2PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080193481-A1 | Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines | GOVERNORS OF THE UNIVERSITY OF ALBERTA | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080193481-A1 | Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines | DDOST, FUT5, STT3B | GJB2 2649/4885NT5E 3272/4885SLC6A2 4614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.